BSE filing, BSE: 543391. Summary written from the filing by ALFA Finder's alert engine.
Suyog Gurbaxani Funicular Ropeways Ltd: key numbers
- Share price
- ₹81.00
- Market cap
- ₹201.4 Cr
- Revenue (annual)
- ₹49.79 Cr
- Net profit (annual)
- ₹5.95 Cr
- P/E (TTM)
- 33.9×Sector 32.4×
- Promoter holding
- 63.04%-0.29% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suyog Gurbaxani Funicular Ropeways Ltd
All →Suyog Gurbaxani Funicular Ropeways Promoter Reclassification
Suyog Gurbaxani Funicular Ropeways Ltd has reclassified Mr. Somnath Gurushant Lature from the Promoter Group to the Public category following shareholder and exchange approval.
Suyog Gurbaxani Funicular Ropeways Annual Report
Suyog Gurbaxani Funicular Ropeways Ltd has submitted a revised Annual Report for the financial year 2025-26 to rectify typographical errors.
Suyog Gurbaxani Funicular Ropeways Management Change
Suyog Gurbaxani Funicular Ropeways Limited announced the appointment of B. Padmanabhan as an Independent Director and the re-appointment of two Non-Executive Directors.
Suyog Gurbaxani Funicular Ropeways Annual General Meeting
The company conducted its 17th Annual General Meeting on September 29, 2026. Shareholders adopted financial statements, re-appointed directors, and approved a dividend of Re. 0.50 per share.
Suyog Gurbaxani Funicular Ropeways Annual General Meeting
Suyog Gurbaxani Funicular Ropeways Limited will hold its 17th Annual General Meeting on September 29, 2026, through video conferencing to transact routine business and dividend declaration.
Suyog Gurbaxani Funicular Ropeways Dividend
Suyog Gurbaxani Funicular Ropeways recommended a final dividend of Re. 0.50 per share for FY 2025-26. The record date is set for September 22, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.